Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations

被引:94
|
作者
Arendrup, Maiken Cavling [1 ]
Perlin, David S. [2 ]
Jensen, Rasmus Hare [1 ]
Howard, Susan Julie [3 ]
Goodwin, Joanne [3 ]
Hope, William [3 ]
机构
[1] Statens Serum Inst, Unit Mycol & Parasitol, DK-2300 Copenhagen, Denmark
[2] UMDNJ New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ USA
[3] Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Translat Res Facil Resp Med, Univ Hosp S Manchester NHS Fdn Trust, Manchester, Lancs, England
基金
美国国家卫生研究院;
关键词
INVASIVE CANDIDIASIS; REDUCED SUSCEPTIBILITY; AMPHOTERICIN-B; ALBICANS; TROPICALIS; ECHINOCANDINS; SUBSTITUTIONS; EPIDEMIOLOGY; ESOPHAGITIS; FLUCONAZOLE;
D O I
10.1128/AAC.06369-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We recently observed that the micafungin MICs for some Candida glabrata fks hot spot mutant isolates are less elevated than those for the other echinocandins, suggesting that the efficacy of micafungin may be differentially dependent on such mutations. Three clinical C. glabrata isolates with or without (S3) fks hot spot mutations R83 (Fks2p-S663F) and RR24 (Fks1p-S629P) and low, medium, and high echinocandin MICs, respectively, were evaluated to assess the in vivo efficacy in an immunocompetent mouse model using three doses of each echinocandin. Drug concentrations were determined in plasma and kidneys by high-performance liquid chromatography (HPLC). A pharmacokinetic-pharmacodynamic mathematical model was used to define the area under the concentration-time curve (AUC) that produced half-and near-maximal activity. Micafungin was equally efficacious against the S3 and R83 isolates. The estimates for the AUCs of each echinocandin that induced half-maximal effect (E(50)s) were 194.2 and 53.99 mg . h/liter, respectively. In contrast, the maximum effect (E-max) for caspofungin was higher against S3 than R83, but the estimates for E-50 were similar (187.1 and 203.5 mg . h/liter, respectively). Anidulafungin failed to induce a >= 1-log reduction for any of the isolates (AUC range, 139 to 557 mg . h/liter). None of the echinocandins were efficacious in mice challenged with the RR24 isolate despite lower virulence (reduced maximal growth, prolonged lag phase, and lower kidney burden). The AUC associated with half-maximal effect was higher than the average human exposure for all drug-dose-bug combinations except micafungin and the R83 isolate. In conclusion, differences in micafungin MICs are associated with differential antifungal activities in the animal model. This study may have implications for clinical practice and echinocandin breakpoint determination, and further studies are warranted.
引用
收藏
页码:2435 / 2442
页数:8
相关论文
共 50 条
  • [41] Monitoring of Fluconazole and Caspofungin Activity against In Vivo Candida glabrata Biofilms by Bioluminescence Imaging
    Persyn, Aranka
    Rogiers, Ona
    Brock, Matthias
    Vande Velde, Greetje
    Lamkanfi, Mohamed
    Jacobsen, Ilse D.
    Himmelreich, Uwe
    Lagrou, Katrien
    Van Dijck, Patrick
    Kucharikova, Sona
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (02)
  • [42] Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient
    Krogh-Madsen, M
    Arendrup, MC
    Heslet, L
    Knudsen, JD
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (07) : 938 - 944
  • [43] Development of echinocandin resistance in Candida krusei isolates following exposure to micafungin and caspofungin in a BM transplant unit
    E Tavernier
    M Desnos-Ollivier
    F Honeyman
    M Srour
    A Fayard
    J Cornillon
    K Augeul-Meunier
    D Guyotat
    H Raberin
    Bone Marrow Transplantation, 2015, 50 : 158 - 160
  • [44] Development of echinocandin resistance in Candida krusei isolates following exposure to micafungin and caspofungin in a BM transplant unit
    Tavernier, E.
    Desnos-Ollivier, M.
    Honeyman, F.
    Srour, M.
    Fayard, A.
    Cornillon, J.
    Augeul-Meunier, K.
    Guyotat, D.
    Raberin, H.
    BONE MARROW TRANSPLANTATION, 2015, 50 (01) : 158 - 160
  • [45] In Vitro Antifungal Susceptibility of Candida glabrata to Caspofungin and the Presence of FKS Mutations Correlate with Treatment Response in an Immunocompromised Murine Model of Invasive Infection
    Fernandez-Silva, Fabiola
    Lackner, Michaela
    Capilla, Javier
    Mayayo, Emilio
    Sutton, Deanna
    Castanheira, Mariana
    Fothergill, Annette W.
    Lass-Floerl, Cornelia
    Guarro, Josep
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 3646 - 3649
  • [46] Synergistic Activities of Three Triazoles with Caspofungin against Candida glabrata Isolates Determined by Time-Kill, Etest, and Disk Diffusion Methods
    Kiraz, Nuri
    Dag, Ilknur
    Yamac, Mustafa
    Kiremitci, Abdurrahman
    Kasifoglu, Nilgun
    Oz, Yasemin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) : 2244 - 2247
  • [47] Do Candida albicans Isolates with Borderline Resistant Micafungin MICs Always Harbor FKS1 Hot Spot Mutations?
    Spettel, Kathrin
    Galazka, Sonia
    Kriz, Richard
    Camp, Iris
    Willinger, Birgit
    JOURNAL OF FUNGI, 2021, 7 (02) : 1 - 7
  • [48] Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure
    Arastehfar, Amir
    Daneshnia, Farnaz
    Salehi, Mohammadreza
    Yasar, Melike
    Hosbul, Tugrul
    Ilkit, Macit
    Pan, Weihua
    Hagen, Ferry
    Arslan, Nazli
    Turk-Dagi, Hatice
    Hilmioglu-Polat, Suleyha
    Perlin, David S.
    Lass-Floerl, Cornelia
    MYCOSES, 2020, 63 (09) : 911 - 920
  • [49] In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin:: Six years of global surveillance (vol 46, pg 150, 2008)
    Pfaller, M. A.
    Boyken, L.
    Hollis, R. J.
    Kroeger, J.
    Messer, S. A.
    Tendolkar, S.
    Diekema, D. J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (09) : 3184 - 3185
  • [50] Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method
    Espinel-Ingroff, A.
    Alvarez-Fernandez, M.
    Canton, E.
    Carver, P. L.
    Chen, S. C. -A.
    Eschenauer, G.
    Getsinger, D. L.
    Gonzalez, G. M.
    Govender, N. P.
    Grancini, A.
    Hanson, K. E.
    Kidd, S. E.
    Klinker, K.
    Kubin, C. J.
    Kus, J. V.
    Lockhart, S. R.
    Meletiadis, J.
    Morris, A. J.
    Pelaez, T.
    Quindos, G.
    Rodriguez-Iglesias, M.
    Sanchez-Reus, F.
    Shoham, S.
    Wengenack, N. L.
    Borrell Sole, N.
    Echeverria, J.
    Esperalba, J.
    Gomez-G de la Pedrosa, E.
    Garcia Garcia, I.
    Linares, M. J.
    Marco, F.
    Merino, P.
    Peman, J.
    Perez del Molino, L.
    Rosello Mayans, E.
    Rubio Calvo, C.
    Ruiz Perez de Pipaon, M.
    Yaguee, G.
    Garcia-Effron, G.
    Guinea, J.
    Perlin, D. S.
    Sanguinetti, M.
    Shields, R.
    Turnidge, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (11) : 6725 - 6732